
Travere Therapeutics, Inc.
USD57.84
-0.46 (-0.78%)
CEO
Eric Dube
IPO Date
2012-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$58.61
Prev. Close
$58.30
Day Low
$57.77
Day High
$58.69
52W Low
$14.36
52W High
$60.10
Market Cap
$5.38B
Volume
0.62M
| 15 Jun 2026 |
| Citigroup |
| Buy |
| Buy |
| maintain |
| 12 Jun 2026 | Wells Fargo | Overweight | Overweight | maintain |
| 3 Jun 2026 | Wedbush | Outperform | Outperform | maintain |
| 3 Jun 2026 | Citigroup | Buy | Buy | maintain |
| 2 Jun 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 6 May 2026 | Wells Fargo | Overweight | Overweight | maintain |
| 5 May 2026 | HC Wainwright & Co. | Buy | Buy | maintain |